COMPASS Pathways plc
CMPS
Rank in Stocks
#7571
COMPASS Pathways plc is a mental healthcare company with a primary presence in... COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Share Price
$9.18
Last synced: 2026-11-09
Market Cap
$1.30B
Change (1 day)
6.62%
Change (1 year)
61.05%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade COMPASS Pathways plc (CMPS)
Category
Healthcare
EPS for COMPASS Pathways plc (CMPS)
EPS as of September 2026 TTM: $-4.20
According to COMPASS Pathways plc's latest financial reports, its current EPS (TTM) is $-4.20. At the end of 2025 the company had an EPS of $-3.08, a decrease compared to its 2024 EPS of $-2.30.
EPS history for COMPASS Pathways plc from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-4.20 | 36.36% |
| 2025 | $-3.08 | 33.91% |
| 2024 | $-2.30 | -0.86% |
| 2023 | $-2.32 | 7.41% |
| 2022 | $-2.16 | 20.67% |
| 2021 | $-1.79 | 6.55% |
| 2020 | $-1.68 | 86.67% |
| 2019 | $-0.90 | -61.70% |
| 2018 | $-2.35 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -472.86% |
US
|
|
| $-7.07 | 68.33% |
US
|
|
| $-5.29 | 25.95% |
AU
|
|
| $12.88 | -406.67% |
BE
|
|
| $21.56 | -613.33% |
NL
|
Questions about COMPASS Pathways plc's earnings per share (EPS)
What is COMPASS Pathways plc's earnings per share (EPS)?
COMPASS Pathways plc's earnings per share (EPS) over the last twelve months is $-4.20, as of Sep 2026.
What was COMPASS Pathways plc's earnings per share (EPS) in 2025?
In 2025, COMPASS Pathways plc's earnings per share (EPS) was $-3.08, compared with $-2.30 in 2024.
How has COMPASS Pathways plc's earnings per share (EPS) changed since 2020?
From 2020 to 2025, COMPASS Pathways plc's earnings per share (EPS) was highest in 2020 ($-1.68) and lowest in 2025 ($-3.08).
How does COMPASS Pathways plc's earnings per share (EPS) compare with similar companies?
COMPASS Pathways plc's earnings per share (EPS) ($-4.20) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.